SE417965B - Forfarande for framstellning av 1-t-alkyl-3-(substituerad-tienyl respektive -tietyl)-karbamid-s,s-dioxid-derivat med antihypertensiv aktivitet - Google Patents

Forfarande for framstellning av 1-t-alkyl-3-(substituerad-tienyl respektive -tietyl)-karbamid-s,s-dioxid-derivat med antihypertensiv aktivitet

Info

Publication number
SE417965B
SE417965B SE7503523A SE7503523A SE417965B SE 417965 B SE417965 B SE 417965B SE 7503523 A SE7503523 A SE 7503523A SE 7503523 A SE7503523 A SE 7503523A SE 417965 B SE417965 B SE 417965B
Authority
SE
Sweden
Prior art keywords
tythyl
carbamid
tienyl
substituted
alkyl
Prior art date
Application number
SE7503523A
Other languages
English (en)
Swedish (sv)
Other versions
SE7503523L (sv
Inventor
P E Aldrich
G H Berezin
B I Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of SE7503523L publication Critical patent/SE7503523L/xx
Publication of SE417965B publication Critical patent/SE417965B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7503523A 1974-04-17 1975-03-26 Forfarande for framstellning av 1-t-alkyl-3-(substituerad-tienyl respektive -tietyl)-karbamid-s,s-dioxid-derivat med antihypertensiv aktivitet SE417965B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (2)

Publication Number Publication Date
SE7503523L SE7503523L (sv) 1975-10-20
SE417965B true SE417965B (sv) 1981-04-27

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7503523A SE417965B (sv) 1974-04-17 1975-03-26 Forfarande for framstellning av 1-t-alkyl-3-(substituerad-tienyl respektive -tietyl)-karbamid-s,s-dioxid-derivat med antihypertensiv aktivitet

Country Status (21)

Country Link
US (1) US4009847A (ja)
JP (1) JPS50148349A (ja)
AR (1) AR208545A1 (ja)
CA (1) CA1047042A (ja)
CH (1) CH611292A5 (ja)
DD (1) DD117223A5 (ja)
DE (1) DE2516554A1 (ja)
DK (1) DK164175A (ja)
ES (1) ES436648A1 (ja)
FI (1) FI751128A (ja)
FR (1) FR2267773B1 (ja)
GB (1) GB1461209A (ja)
HU (1) HU173052B (ja)
IE (1) IE41143B1 (ja)
IL (1) IL47095A (ja)
LU (1) LU72306A1 (ja)
NL (1) NL7504570A (ja)
NO (1) NO144071C (ja)
PH (1) PH11722A (ja)
SE (1) SE417965B (ja)
YU (1) YU96075A (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2377847T3 (es) * 1999-01-13 2012-04-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ME00275B (me) 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
PT2305255E (pt) * 2001-12-03 2012-09-04 Bayer Healthcare Llc Compostos de arilureia em combinação com outros agentes citostáticos ou citotóxicos para tratamento de cancros humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
EP1474393A1 (en) * 2002-02-11 2004-11-10 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
SI1478358T1 (sl) * 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
US7557129B2 (en) * 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
DK1626714T3 (da) * 2003-05-20 2007-10-15 Bayer Pharmaceuticals Corp Dirarylurinstoffer mod sygdomme medieret af PDGFR
RS52625B (en) * 2003-07-23 2013-06-28 Bayer Healthcare Llc FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
EP1751139B1 (en) * 2004-04-30 2011-07-27 Bayer HealthCare LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
ES436648A1 (es) 1977-08-01
NL7504570A (nl) 1975-10-21
GB1461209A (en) 1977-01-13
JPS50148349A (ja) 1975-11-27
NO144071B (no) 1981-03-09
NO751351L (ja) 1975-10-20
FR2267773A1 (ja) 1975-11-14
LU72306A1 (ja) 1976-03-17
IL47095A (en) 1978-03-10
IL47095A0 (en) 1975-06-25
CH611292A5 (ja) 1979-05-31
IE41143L (en) 1975-10-17
DD117223A5 (ja) 1976-01-05
AR208545A1 (es) 1977-02-15
US4009847A (en) 1977-03-01
NO144071C (no) 1981-06-17
YU96075A (en) 1983-04-27
IE41143B1 (en) 1979-10-24
AU8013575A (en) 1976-10-21
CA1047042A (en) 1979-01-23
FR2267773B1 (ja) 1978-08-18
DK164175A (da) 1975-10-18
PH11722A (en) 1978-05-30
DE2516554A1 (de) 1975-10-30
FI751128A (ja) 1975-10-18
SE7503523L (sv) 1975-10-20
HU173052B (hu) 1979-02-28

Similar Documents

Publication Publication Date Title
SE417965B (sv) Forfarande for framstellning av 1-t-alkyl-3-(substituerad-tienyl respektive -tietyl)-karbamid-s,s-dioxid-derivat med antihypertensiv aktivitet
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE428562C (sv) Forfarande for framstellning av purinderivat
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
SE415761B (sv) Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE422791B (sv) Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE7504842L (sv) Forfarande for framstellning av adeninderivat..
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE415354B (sv) Forfarande for framstellning av xantinderivat
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE416053B (sv) Forfarande for framstellning av 7alfa-metylostr-4-en-3alfa, 17beta-diol
SE422057B (sv) Forfarande for framstellning av vissa omega-substituerade omega-nor-13,14-dehydro-prostaglandiner
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE425784B (sv) Analogiforfarande for framstellning av eburnameninderivat
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE401833B (sv) Forfarande for framstellnig av vissa angivna 1,2,4-friazolderivat
SE417966B (sv) Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat